BioWorld: The Daily Biopharmaceutical and Medical Technology …
These cookies are used to enable social media sharing or “like” buttons on our services. They also provide the ability to link your account or engage with our content on or through a social media platform such as Facebook, Twitter or LinkedIn.
BioWorld: The Daily Biopharmaceutical News Source
Joining the dealmaking spree to kick off the 2025 J.P. Morgan Healthcare Conference, Eli Lilly and Co. announced it was picking up an early clinical-stage PI3Kα inhibitor program from Scorpion Therapeutics Inc. in a deal that could be worth up to $2.5 billion, while GSK plc is adding to its cancer pipeline with the acquisition of Idrx Inc. for $1 billion up front.
Other news to note for January 14, 2025 | BioWorld
1 day ago · Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: E8, Adaptive Biotechnologies, Aignostics , Bostongene ...
BioWorld Science: The Daily Drug R&D News Source
Daily news focused on drug discovery, delivery and preclinical research. Coverage includes: Congress highlights, key studies from peer-reviewed journals, chemical structure images, pharmacology news that delineates drug/receptor and enzyme/target cell interactions, newly reported experimental models, and relationships between genes and diseases to gain insight into underlying biological ...
Other news to note for Jan. 14, 2025 | BioWorld
1 day ago · Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arsenal, Banner, Bausch + Lomb, Bausch Health, Biomea, BMS ...
China - Articles - BioWorld
Jan 8, 2025 · China’s health regulator gave conditional approval to Platinum Life Excellence Biotech Co. Ltd.’s amimestrocel injection (hUC-MSC PLEB-001, Ruibosheng) as the nation’s first human umbilical cord-derived mesenchymal stem cell therapy to treat steroid-refractory acute graft-vs.-host disease on Jan. 2, 2025.
Today's news in brief - BioWorld
Jan 3, 2025 · BioWorld MedTech briefs for January 3, 2025. Appointments and advancements for January 3, 2025. New hires and promotions in the med-tech industry, including: Genedx, Intuitive Surgical.
Today's news in brief | BioWorld
BioWorld briefs for Jan. 2, 2025.
Other news to note for Jan. 29, 2024 | BioWorld
Jan 29, 2024 · Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ABL, Cristalia, Debiopharm, Formosa, Gamida Cell, Institut ...
Biopharma kicks off strong in 2024, raising more than $10B
The biopharma industry started 2024 on the upswing, with all four categories of financings tracked by BioWorld up in value compared to last January, and also up from December. In comparison to January 2023, IPO value soared 262%, follow-ons surged by 247%, public/other offerings saw a 381% rise, and private financings experienced a 21% bump.